Join our next SOSV Deep Tech LIVE for a rare fireside chat with Professor James Rothman, Ph.D., winner of the 2013 Nobel Prize in Physiology or Medicine and Sterling Professor of Cell Biology at Yale University. Rothman’s pioneering discoveries revealed the molecular mechanisms that control transport within cells—a breakthrough that laid the foundation for modern biotechnology and helped pave the way for today’s nanobiology revolution.

Plasma is the foundational technology behind semiconductor fabrication — and without it, Moore’s Law would have stalled decades ago. Now, as silicon transistors hit their physical limits, the industry is turning to new materials, chip architectures, advanced packaging, and novel device physics to sustain performance gains, improve energy efficiency, and reduce compute costs, all while navigating the explosive demand driven by AI. At this critical inflection point, we’re joined by Dr. Rick Gottscho, Retired Head of Products & CTO of Lam Research, who will make the case for why plasma’s most important moment is right now.

Announcing the 2026 VC-Founder Therapeutics Matchup, with meetings taking place online between July 13th (Monday) and July 17th (Friday). This virtual event will bring together 200+ startups and 100+ investors for 1:1 meetings online, scheduled at mutually convenient times. It is designed to connect investors with founders building the next generation of therapeutics companies, across […]

Building the next generation of plasma-powered companies in Princeton, NJ.

AI is rapidly reshaping the way venture firms operate — from sourcing and diligence to portfolio support, internal knowledge systems, decision-making, and more. ​But beyond the hype, what does agentic venture capital actually look like in practice? On June 4, as part of NY Tech Week, SOSV is bringing together a small group of New […]

OpenAI, Anthropic, Google, and others have all taken unusual steps to limit who controls their most consequential decisions. Most AI startups haven’t. As the technology accelerates, that gap may matter more than anyone wants to admit. Join author and investor Eric Ries — whose new book Incorruptible explores what it takes to build companies that resist the pull of short-term financial pressures — for a frank conversation on whether the startup world needs a new governance playbook, and what’s at stake if it doesn’t.

Picture this: Acres of cotton all around you. 150,000 plants. Now, harvest them all, collect the seeds — all 45 million of them — and start sequencing genomes.

SOSV portfolio company Prolific Machines recently spoke to FiercePharma following a big milestorne for its photomolecular platform, which uses light and optogenetics to “directly and dynamically” manipulate gene expression in living cells. The company announced it has achieved 21 g/L productivity over 15 days in an intensified fed-batch Chinese hamster ovary (CHO) cell line run […]

At our latest SOSV Deep Tech Live, we sat down with a panel of world leaders in plasma to explore ​how plasma is quickly becoming one of the most important…and misunderstood..forces shaping the future of semiconductors, clean manufacturing, advanced materials, and of course, clean energy. While much of today’s AI conversation centers on LLMs that […]

SOSV portfolio company, Fermeate, recently spoke to AgFunder News following it raised a $2 million Seed round led by Newfund Capital with participation from SOSV, Ajinomoto Group Ventures, Ki Tua Fund, Heuristic Capital Partners, Momentum Capital, Plug and Play, Tesserkat Ventures, and Ag Startup Engine, to bring optogenetics into industrial fermentation. Its platform uses light to precisely control gene expression in living […]